Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$2.90 USD
+0.06 (2.11%)
Updated Jul 22, 2024 03:59 PM ET
After-Market: $2.87 -0.03 (-1.03%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 48.57% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.14 |
Next Year | -0.76 |
EPS (TTM) | -0.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.31 | -1.14 | -0.76 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.28 | -0.31 | -1.14 | -0.76 |
High Estimate | -0.28 | -0.31 | -1.14 | -0.76 |
Low Estimate | -0.28 | -0.31 | -1.14 | -0.76 |
Year ago EPS | -0.34 | -0.19 | -0.91 | -1.14 |
Year over Year Growth Est. | 17.65% | -63.16% | -25.27% | 33.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | -0.28 | -0.31 | -1.14 | -0.76 |
7 Days Ago | -0.28 | -0.31 | -1.14 | -0.76 |
30 Days Ago | NA | NA | -1.29 | -0.93 |
60 Days Ago | NA | NA | -1.29 | -0.93 |
90 Days Ago | NA | NA | -1.29 | -0.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.31 | -1.14 | -0.76 |
Zacks Consensus Estimate | -0.28 | -0.31 | -1.14 | -0.76 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.21 | -0.19 | -0.34 | NA |
Estimate | -0.35 | -0.30 | -0.29 | -0.63 | NA |
Difference | 0.17 | 0.09 | 0.10 | 0.29 | 0.16 |
Surprise | 48.57% | 30.00% | 34.48% | 46.03% | 39.77% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more